Vivacelle Bio
Chicago, US · Founded 2013 · 1 known investors
Leverages phospholipid nanoparticles to treat hypovolemia due to septic or hemorrhagic shock.
Biotech
Founders & leadership
RO
Ron Ormand DamperDirector
HO
Harven Ormand DeShieldExecutive Officer, Director
SO
Stephen Ormand KeithExecutive Officer, Director
CO
Cuthbert Ormand SimpkinsExecutive Officer, Director
DO
Diane Ormand SimpkinsExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.9MraisedFeb 2019 · 59 investors · Other Technology
Rule 506(b)$1.3MraisedSep 2016 · 58 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.